Luxsol™ Test Facility

Texas Biomedical Research Institute. Texas Biomedical Research Institute is one of very few privately-owned facilities that have both BSL3 and BSL4 capabilities in the United States.

3V Medical performed in vitro and in vivo studies of their targeted treatment for SARs CoV-2 infection and Influenza at Texas Biomedical Research Institute located in San Antonio, Texas.

In Vitro Study Assessment of the Effect of 3VM1000 Suspension on SARS-CoV-2 Infectivity.

Currently, Texas Biomedical Research Institute is conducting Aim 2 study using 3VM-1000 suspension solution for the effectiveness to treat SARS-CoV2.